How the COVID-19 pandemic broke the innovation pain barrier

View the accessible transcript of this podcast

Emma Lowe talks to Professor Allan Gaw about how the UK was able to get world-renowned, innovative platforms trials - such as RECOVERY, REMAP-CAP and PRINCIPLE - up and running at record speed in order to rapidly deliver answers about which medicines were effective in treating COVID.

She reflects on how the uptake and acceptance of forward-thinking trial designs and delivery techniques accelerated during the pandemic as innovation went mainstream. She also zooms in on other stand out features such as the flexibility of the regulators, the ingenious use of data to direct and manange research resources, and the shift in mindset which saw decentralised and virtual trials being delivered in peoples homes.

This podcast is part of our 'Persectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517

To find out more about how the NIHR supports complex and innovative design trials, visit: www.nihr.ac.uk/innovative-trials

You can listen to all our full collection of #ComplexInnovativeDesign trial podcasts on our website.